- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1861-0714
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Lipoprotein(a)—antisense therapy ; volume:14 ; number:1 ; day:11 ; month:3 ; year:2019 ; pages:51-56 ; date:4.2019
Clinical research in cardiology supplements ; 14, Heft 1 (11.3.2019), 51-56, 4.2019
- Urheber
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s11789-019-00096-2
- URN
-
urn:nbn:de:101:1-2019051322203907925440
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:49 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Vogt, Anja
- SpringerLink (Online service)
Ähnliche Objekte (12)
Antisense and ribozyme methodology
Antisense research and application
Antisense and ribozyme methodology
Lipoprotein und apolipoprotein abnormalities in children undergoing maintenance hemodialysis therapy
Postmenopausal Hormone Replacement Therapy with Tibolone Decreases Serum Lipoprotein(a)
Antisense oligonucleotide-based therapy against Fra-2, a novel target in liver fibrosis
Evaluation of serum MMP-9 as predictive biomarker for antisense therapy in Duchenne
Lipoprotein subfractions
Lipoprotein metabolism
Lipoprotein metabolism
Lipoprotein(a)
Lipoprotein (a)
Antisense and ribozyme methodology
Antisense research and application
Antisense and ribozyme methodology
Lipoprotein und apolipoprotein abnormalities in children undergoing maintenance hemodialysis therapy
Postmenopausal Hormone Replacement Therapy with Tibolone Decreases Serum Lipoprotein(a)
Antisense oligonucleotide-based therapy against Fra-2, a novel target in liver fibrosis
Evaluation of serum MMP-9 as predictive biomarker for antisense therapy in Duchenne
Lipoprotein subfractions
Lipoprotein metabolism
Lipoprotein metabolism
Lipoprotein(a)
Lipoprotein (a)
Antisense and ribozyme methodology
Antisense research and application
Antisense and ribozyme methodology
Lipoprotein und apolipoprotein abnormalities in children undergoing maintenance hemodialysis therapy
Postmenopausal Hormone Replacement Therapy with Tibolone Decreases Serum Lipoprotein(a)
Antisense oligonucleotide-based therapy against Fra-2, a novel target in liver fibrosis
Evaluation of serum MMP-9 as predictive biomarker for antisense therapy in Duchenne
Lipoprotein subfractions
Lipoprotein metabolism
Lipoprotein metabolism
Lipoprotein(a)